Pharmaceutical marketing aims to shape both patient and clinician perceptions about a drug’s benefit and can significantly impact patient and clinician decisions that then affect outcomes, in addition to draining government and health care system resources.

This paper describes the types of marketing tactics that pharmaceutical companies use and the adverse impacts those tactics can have on patients, clinicians, and the health care system.

Full paper: Drug policy 101: Pharmaceutical marketing tactics

Other papers in this series: